NPR News·4 min read·medium
FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned
S
Sydney Lupkin
✦AI Summary
The FDA is nearing a decision on whether to approve Moderna's mRNA-based flu vaccine after an initial rejection and subsequent reconsideration. The approval process has become a focal point of debate due to the skepticism surrounding mRNA technology expressed by Health Secretary Robert F. Kennedy Jr.
For the latest stories on the science of healthy living, subscribe to NPR's Health newsletter .
healthsciencepolitics
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in